Full Text View
Tabular View
Study Results
Related Studies
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
This study has been completed.
Study NCT00267488   Information provided by GlaxoSmithKline

First Received on December 20, 2005.   Last Updated on June 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial